Natural aminosterols inhibit <scp>NMDA</scp> receptors with low nanomolar potency
Abnormal functions of N-methyl-D-aspartate receptors (NMDARs) are associated with many brain disorders, making them primary targets for drug discovery. We show that natural aminosterols inhibit the NMDAR-mediated increase of intracellular calcium ions in cultured primary neurons and neuroblastoma cells. Structural comparison with known NMDAR-negative allosteric modulators, such as pregnanolone-sulfate-2 (PAS), raises the hypothesis that aminosterols have the same mechanism of action. Fluorescence resonance energy transfer (FRET) measurements using labeled NMDAR and the labeled aminosterol trodusquemine (TRO) indicate close spatial proximity, likely arising from binding. Other indirect yet plausible mechanisms for NMDAR inhibition by TRO were excluded. Electrophysiological patch clamp measurements on primary neurons indicate that pre-incubated TRO inhibits NMDA-induced ion currents with a IC<sub>50</sub> of 5 nm. Inhibition is observed only after cell membrane pre-adsorption, indicating accessibility to NMDAR from the cell membrane and binding to the transmembrane domains (TMDs) and TMD-ligand-binding domain (LBD) linkers, similarly to PAS. The TRO IC<sub>50</sub> is 5000-fold higher than that of PAS and 20-16 000 times higher than those of other inhibitors binding to TMD/TMD-LBD regions, identifying aminosterols as promising and potent NMDAR modulators.
Authors
- M. Gennari
- Federica Cherchi (ORCID: https://orcid.org/0000-0001-6742-456X)
- Anna Maria Pugliese (ORCID: https://orcid.org/0000-0001-7554-5740)
- Giulia Fani (ORCID: https://orcid.org/0000-0003-2831-7811)
- Fabrizio Chiti (ORCID: https://orcid.org/0000-0002-1330-1289)
- Michael Zasloff (ORCID: https://orcid.org/0000-0002-1453-9328)
- Michele Vendruscolo (ORCID: https://orcid.org/0000-0002-3616-1610)
- Elisabetta Coppi (ORCID: https://orcid.org/0000-0003-4434-5919)
- Silvia Errico
- Denise Barbut (ORCID: https://orcid.org/0000-0002-0181-3818)
Institutions
- Georgetown University (US)
- University of Cambridge (GB)
- MedStar Georgetown University Hospital (US)
- Treatment Research Institute (US)
- University of Florence (IT)
Publication Details
- Journal
- FEBS Journal
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1111/febs.70072
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Regione Toscana
- Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze